Welcome to Sun-shine chemical
+86-27-65522453 sales@sun-shinechem.com


Catalog No.: 611920
Cas No.: 1421693-22-2
Purity : 98% 

CDKI-73 is a potent CDK9 inhibitor with Ki of 4 nM; shows selective toxicity to CLL cells(LD50=80 nM) versus normal B cell and normal CD34+ cell(LD50>20 uM).

CDKI-73 was cytotoxic to all of the CLL samples tested (n = 38) with a mean LD50 value of 0.08M 0.10 M following exposure to drug for 48h. In contrast, normal B-lymphocytes (n = 10) and CD34+ normal bone marrow cells (n = 5) were significantly less susceptible to the cytotoxic effects of CDKI-73. Treatment of CLL cells with 0.1 M CDKI-73 for 4h inhibited the phosphorylation of cdk9 and ser2 of RNA polymerase II. CDKI-73 induces a rapid loss of MCL1 protein and this is mediated by significant inhibition at the level of gene transcription. However, this inhibition is not restricted to MCL1 as similar reductions in XIAP and CCND2 were also observed following exposure to CDKI-73 for 4h [1]. CDKI-73 rapidly inhibited cellular CDK9 kinase activity and down-regulated the RNAPII phosphorylation. CDK9 shRNA was also found to down-regulate the Mnk1 expression. Both CDKI-73 and CDK9 shRNA decreased anti-apoptotic proteins Mcl-1 and Bcl-2 and induced apoptosis [2].


For research use only. We do not sell to patients.

Chemical Information

Iupac Chemical NameCDKI-73 
Molecular FormulaC15H15FN6O2S2 
Molecular Weight394.45 
CAS Number1421693-22-2
Related CAS

Ordering Information

PackagingPriceAvailabilityPurityShipping Time
Request Bulk Quote Download MSDS Tel : +86-27-65522453   Email : sales@sun-shinechem.com
Formulationcrystalline solid 
Storage3 years -20ºCpowder 
SolubilitySoluble in DMSO 
Shipping ConditionShipped under ambient temperature as non-hazardous chemical. 
HS Code
Coming soon.
Cell study
Animal study
Clinical study
Not available

Chemical Structure

611920 - CDKI-73 | CAS 1421693-22-2

Quick inquiry